Dr Reddys Laboratories (RDY) Equity Income (2011 - 2019)
Dr Reddys Laboratories (RDY) posted quarterly Equity Income of -$2.0 million for Q3 2019, down 100.0% year-over-year from -$inf billion in Q3 2018, and little changed quarter-over-quarter from -$2.0 million in Q2 2019.
Dr Reddys Laboratories (RDY) Equity Income (2011 - 2019) Analysis & Trends
Dr Reddys Laboratories' Equity Income history runs 6 years deep, the most recent figure standing at -$2.0 million for Q3 2019.
- In Q3 2019, Equity Income fell 100.0% year-over-year to -$2.0 million; the TTM figure through Sep 2019 stood at -$8.0 million (down 100.0% YoY), while the FY2019 annual figure was -$2.0 million, down 100.0% from the prior year.
- Equity Income for Q3 2019 stood at -$2.0 million, roughly flat from -$2.0 million in the prior quarter.
- The five-year high for Equity Income was -$1.0 million in Q3 2017, with the low at -$2.0 million in Q4 2016.
- The 4-year median for Equity Income is -$2.0 million (2016), against an average of -$1.6 million.
- The sharpest annual moves came in 2017 and 2018: Equity Income soared 50.0% in 2017, then tumbled 100.0% in 2018.
- Dr Reddys Laboratories' Equity Income stood at -$2.0 million in 2016, then jumped by 50.0% to -$1.0 million in 2017, then sank by 100.0% to -$2.0 million in 2018, then changed by 0.0% to -$2.0 million in 2019.
- Business Quant data shows RDY's Equity Income at -$2.0 million in Q3 2019, -$2.0 million in Q2 2019, and -$2.0 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -500,000.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 3.38 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.42 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -2.00 Mn |
| Jun 30, 2019 | -2.00 Mn |
| Mar 31, 2019 | -2.00 Mn |
| Dec 31, 2018 | -2.00 Mn |
| Sep 30, 2018 | -1.00 Mn |
| Mar 31, 2018 | -1.00 Mn |
| Dec 31, 2017 | -1.00 Mn |
| Sep 30, 2017 | -1.00 Mn |
| Dec 31, 2016 | -2.00 Mn |
| Sep 30, 2012 | -1.00 Mn |
| Jun 30, 2012 | -28.00 Mn |
| Mar 31, 2012 | -19.00 Mn |
| Dec 31, 2011 | -12.00 Mn |
| Sep 30, 2011 | 514.00 Mn |